Início › Mieloma Múltiplo › Wisconsin
Ensaios clínicos de Mieloma Múltiplo em Wisconsin
28 estudos para Mieloma Múltiplo estão buscando participantes em locais em Wisconsin.
Cidades em Wisconsin
Texto oficial do estudo (Inglês)
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
- Mayo Clinic Health System-Eau Claire Clinic, Eau Claire
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06630104A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Research Site, Madison
- Research Site, Milwaukee
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07391657A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- University of Wisconsin Carbone Cancer Center, Madison
- Medical College of Wisconsin, Milwaukee
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT04973605A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Medical College Of Wisconsin, Milwaukee
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07258511A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Froedtert Memorial, Milwaukee
RecrutandoFase 4
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05201781A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
- The Medical College of Wisconsin, Milwaukee
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07116616TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Aurora Cancer Care - Burlington, Burlington
- Aurora Health Care - Germantown Health Center, Germantown
- Aurora Cancer Care - Grafton, Grafton
- e mais 13
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT02693535Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Medical College of Wisconsin, Milwaukee
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07648264A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Medical College of Wisconsin, Milwaukee
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06615479Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06297226Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
- University of Wisconsin, Madison
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07479979A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
- Research Site, Milwaukee
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07681596MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center-University Hospital, Madison
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT06152575Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- ThedaCare Regional Cancer Center, Appleton
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield
- e mais 47
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04566328Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Gundersen Lutheran, La Crosse
RecrutandoFase 3
Idades de 18 a 79 · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT07285239AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Milwaukee
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05850234Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
- Froedtert & the Medical College of Wisconsin, Milwaukee
RecrutandoFase 1
Idades de 18 a 80 · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT05976555A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Wisconsin - Carbone Cancer Center, Madison
- MCW-Clinical Cancer Center at Froedtert Hospital Campus, Milwaukee
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07284758Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
- Medical College of Wisconsin, Milwaukee
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT07236502Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Langlade Hospital and Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- e mais 22
RecrutandoFase 3
Todas as idades · Todos os sexos · Atualizado em 10 de jun. de 2026 · NCT05561387Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- St Vincent HSHS (Green Bay Oncology), Green Bay
- University of Wisconsin Hospital and Clinics, Madison
- Froedtert Memorial Lutheran Hospital, Milwaukee
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT05243797Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
- University of Wisconsin Clinical Science Center, Madison
- Medical College of Wisconsin, Milwaukee
RecrutandoFase 2
Idades 19 e acima · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT06974786Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 1 de abr. de 2026 · NCT05862012Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de jan. de 2026 · NCT04240054Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
- Froedtert & the Medical College of Wisconsin, Milwaukee
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 5 de jan. de 2026 · NCT07093554Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
RecrutandoEstudo observacional
Idades de 18 a 80 · Todos os sexos · Atualizado em 10 de nov. de 2025 · NCT03375619CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
- Froedtert and the Medical College of Wisconsin, Milwaukee
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2025 · NCT05722418Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.